🟢 ASBP is trading 7% up today on Amazon Buzz Bomb launch and ahead of Life Sciences Investor Forum appearance

ASBP is trading 7% up at $6.60 today, driven by the nationwide Amazon launch of its innovative BUZZ BOMB™ 50mg caffeine stick packs and ahead of its scheduled presentation at the Life Sciences Investor Forum on June 25, 2026.

• The Amazon launch of BUZZ BOMB™ expands Aspire Biopharma's consumer focus with a new rapid-dissolve caffeine powder.
• Investor interest also focuses on the company's lead high-dose aspirin candidate, which has demonstrated a faster therapeutic impact than standard chewed aspirin and is expected to improve its competitive position.
• The upward move follows a period of recent price weakness.